Search

everythinglearnresearchcommunity

for

Search:↓

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

A unique gene mutation causes vitamin D-resistant rickets without causing hair loss.

Severe digestive issues in DRESS need early endoscopy for better treatment.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

"D-CHRAMPS syndrome" is a newly identified condition with multiple severe symptoms.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Retinoic acid affects skin and hair health by working with specific receptors, and its absence can lead to hair loss and skin changes.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

Extracellular ATP promotes growth, while adenosine inhibits it in Arabidopsis plants.

Individualized treatments may help manage Dercum's disease symptoms.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Atopic dermatitis increases the risk of some autoimmune diseases.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Squaric acid dibutylester effectively treats alopecia areata.

Squaric acid dibutylester promotes hair growth by activating immune cells, especially macrophages.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

ADEM is a sudden brain disorder often following infection or vaccination, diagnosed by ruling out other conditions.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

An 11-year-old girl with a rare skin disorder also had cornea issues and dry eye, needing careful management.